VIIV expands a license to produce a public incentive in low -income countries (GSK: NYSE)

• Viiv Healthcare, owned by most GSK (New York:GSKShe said that she will expand the licensing agreement with the patent patent group that will allow manufacturers to produce a Cabotegravir General Festival for low -income countries as a long -acting HIV.
• Previously, the agreement

https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345341657/image_1345341657.jpg?io=getty-c-w750

Source link